Table 4 Confirmed ATPalpha ^CJ10 interacting deficiencies

CJ10

Control

50.3 +/− 7.1

17

-

-

-

Df(3R)BSC486

Enh

168.5 +/− 38.8

6

4.92

DTS1

Df(3 L)Exel6112

Enh

144.6 +/− 15.4

18

4.20

CJ5

Df(2 L)BSC180

Enh

151.7 +/− 34.5

9

2.93

Rbp9

DTS1

Df(2 L)TW161

Enh

103.1 +/− 18.2

12

2.89

Df(3R)BSC469

Enh

96.5 +/− 22.9

11

2.59

CJ5

Df(3R)BSC681

Enh

98.7 +/− 49.4

6

2.32

Df(3R)A113

Enh

92.4 +/− 8.8

14

2.16

Df(3R)BSC501

Enh

91.8 +/− 7.8

14

2.10

CG14508

Df(3R)ED5495

Enh

139.6 +/− 34.5

7

1.98

Df(3 L)Exel6092

Enh

142.8 +/− 31.5

20

1.85

spz5, scramb2, FMRFaR, aly

DTS1

Df(2R)BSC664

Enh

60.2 +/− 14.1

11

1.77

Df(3R)Exel6196

Enh

109.1 +/− 28.5

11

1.74

Df(3 L)BSC410

Enh

85.3 +/− 11.1

12

1.54

Df(3 L)ED4475

Sup

8.0 +/− 1.6

7

1.48

CJ5

Df(3 L)BSC23

Sup

8.0 +/− 3.0

18

1.43

rasp, spz5, scramb2, aly

DTS1, CJ5

Df(2 L)BSC240

Enh

91.8 +/− 10.9

24

1.43

Nckx30C, ppk11, nAChR-alpha6, FKBP59

Df(2 L)J39

Sup

7.9 +/− 2.2

25

1.43

FKBP59

CJ5

Df(2R)BSC361

Enh

114.0 +/− 26.3

8

1.29

Stj

DTS1

Df(2R)BSC661

Enh

78.0 +/− 10.9

23

1.25

Df(3R)ED5577

Sup

14.0 +/− 2.0

13

1.20

Df(2 L)ED489

Sup

12.1 +/− 2.6

25

1.19

Ndae1

CJ5

Df(3 L)ED230

Sup

13.7 +/− 3.7

10

1.17

Df(4)ED6380

Sup

12.6 +/− 3.6

25

1.14

Df(3 L)BSC113

Sup

14.3 +/− 1.7

15

1.13

aay

Df(2 L)ED793

Sup

16.2 +/− 4.1

25

1.09

Dyrk2, NimB5, nAChRα5

Df(2 L)BSC149

Sup

16.1 +/− 3.3

14

1.09

Df(3R)ED7665

Sup

16.5 +/− 5.1

21

1.06

DTS1

Df(3 L)BSC442

Enh

79.1 +/− 10.4

15

1.02

Df(3R)BSC467

Enh/Leth

-

-

DTS1

Df(3R)BSC819

Enh/Leth

-

-

ATPalpha

All Enh/Leth